Showing 1 - 5 results of 5 for search 'Julie Lajeunesse', query time: 0.03s
Refine Results
-
1
-
2
-
3
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods sys... by Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter, Eugenia Oviedo-Joekes
Published 2023-09-01
Article -
4
“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises by Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, Kurt Lock, Adam Easterbrook, Scott MacDonald, Scott Harrison, Julie Lajeunesse, David Byres, Martin Schechter, Eugenia Oviedo-Joekes
Published 2023-04-01
Article -
5
Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study by Eugenia Oviedo-Joekes, Sophia Dobischok, José Carvajal, Scott MacDonald, Cheryl McDermid, Piotr Klakowicz, Scott Harrison, Julie LaJeunesse, Nancy Chow, Murray Brown, Sam Gill, Martin Schechter
Published 2023-05-01
Article